Indiana House Bill 1158 (Prior Session Legislation)

---

Spectrum: Slight Partisan Bill (Democrat 2-1)
Status: Introduced on January 10 2023 - 25% progression, died in committee
Action: 2023-02-13 - Representatives Lucas and Miller K added as coauthors
Pending: House Public Health Committee
Text: Latest bill text (Introduced) [PDF]

Breakthrough therapies. Provides that a drug, biological product, or medical device that has been designated as a breakthrough therapy under federal law may be made available to a qualified patient and offered by a physician as a part of the patient's medical treatment. Specifies that a civil or criminal cause of action is not created against a manufacturer or health care provider for any harm to a qualified patient resulting from use of an investigational drug, biological product, or device.

Breakthrough therapies.

Rep. Justin Moed [D]

Rep. Jim Lucas [R]

Rep. Kyle Miller [D]

Date	Chamber	Action
2023-02-13	House	Representatives Lucas and Miller K added as coauthors
2023-01-10	House	First reading: referred to Committee on Public Health
2023-01-10	House	Authored by Representative Moed

Type	Source
Summary	https://iga.in.gov/legislative/2023/bills/house/1158/details
Text	https://iga.in.gov/legislative/2023/bills/house/1158/#1.INTR